Device Trial Radar · NCT07941011
Hyaluronic Acid Barrier in Parotidectomy
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jan 1, 2027
Primary completion
Jan 31, 2029
Study completion Jan 31, 2029
Sponsor
- Lead sponsor
- Milton S. Hershey Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Axogen Corporation
- First posted
- Nov 17, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of AxoGuard HA+ (hyaluronic acid nerve protector) in preventing Frey syndrome following parotidectomy. A parotidectomy is a surgical procedure to remove all or part of the parotid gland, the largest salivary gland located near the ear and jaw. The specific aims are to determine whether placement of AxoGuard HA+ during parotidectomy can significantly reduce both clinical and subclinical incidence of Frey syndrome compared to standard surgical technique alone.
Conditions
- Parotidectomy, Patient-reported Outcomes
- Parotid Cancer
- Parotid Gland Tumor
- Parotidectomy
- Frey's Syndrome
Interventions
Axoguard HA+ Nerve ProtectorDevice
AxoGuard HA+ nerve protector is an FDA-approved device available for clinical use, but its specific efficacy in preventing Frey syndrome following parotidectomy has not been systematically evaluated in controlled trials.
ParotidectomyProcedure
A parotidectomy is a surgical procedure to remove all or part of the parotid gland, the largest salivary gland located near the ear and jaw.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects with positive Starch-Iodine testTime frame: 3 months post-op
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.